US89853L3024 - Common Stock
T2 BIOSYSTEMS INC
NASDAQ:TTOO (4/19/2024, 4:30:07 PM)
After market: 3.2 +0.24 (+8.11%)2.96
-0.03 (-1%)
T2 Biosystems Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Lexington, Massachusetts and currently employs 158 full-time employees. The company went IPO on 2014-08-07. T2 Biosystems, Inc. is an in-vitro diagnostics company. The firm is focused on the detection of sepsis-causing pathogens and antibiotic resistance genes. The firm is using its T2MR technology, which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as low as one colony forming unit per milliliter (CFU/mL). Its primary commercial products include the T2Candida Panel and the T2Bacteria Panel. Its T2Candida Panel is a direct-from-blood test that identifies the lethal form of common bloodstream infections that cause sepsis and candidemia. Its T2Bacteria Panel is a direct-from-blood test that detects certain bacterial pathogens associated with sepsis. Its primary commercial products also include the T2Dx Instrument, the T2Resistance Panel, and the T2SARS-CoV-2 Panel.
T2 BIOSYSTEMS INC
101 Hartwell Ave
Lexington MASSACHUSETTS 02421
P: 17814571200
CEO: John Sperzel
Employees: 158
Website: https://www.t2biosystems.com/
Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics.
LEXINGTON, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and...
LEXINGTON, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and...
Anticipates commercial launch of the T2Lyme Panel in the third quarter of 2024...
LEXINGTON, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing...
TTOO stock is in the green after the company announced that it had received an extension to reach a $35 million market capitalization.
Here you can normally see the latest stock twits on TTOO, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: